The Latest Research for NAFLD!

In the medical world, we are always trying to find new ways to treat all kinds of conditions. Non-alcoholic fatty liver disease, or NAFLD, is a condition that we are constantly learning more about, especially in the work of clinical research. NAFLD has emerged as the most prominent cause of chronic liver disease. So what’s new in NAFLD research? Let’s find out!

PUBLIC SERVICE ANNOUNCEMENT!

NAFLD researchers are urging the public to take care of themselves by declaring NAFLD as a public health priority. They are realizing that the general public does not possess proper knowledge of NAFLD and they desire to change that. At the Digital NAFLD Summit 2021, researchers developed a final set of 37 consensus statements and 26 recommendations. The statements addressed a broad range of topics relevant to policymakers, practitioners, civil society groups, researchers, and affected populations. They hope that these recommendations can bring major change to NAFLD basic knowledge and prevention.

Who Has a Higher Risk of Getting NAFLD?

Anyone can develop NAFLD. Unfortunately, we don’t know everything about this condition. However, clinical research has provided a lot of information about who can get it or what causes fatty liver. We do know that it is more common for people that have the following factors:

  • Type 2 diabetes and prediabetes
  • Obesity
  • Middle-aged or older
  • Hispanic
  • High levels of fats in the blood
  • High blood pressure
  • Take certain drugs
  • Have certain metabolic disorders
  • Experienced rapid weight loss
  • Have certain infections, such as hepatitis C
  • Were exposed to toxins

NAFLD Treatment and Prevention

There is no medication or vaccine approved by the FDA to treat NAFLD. Fortunately, there are ways in which you can reduce or prevent fatty liver. Common suggestions from physicians include:

  • Losing weight
  • Get regular exercise
  • Eating a healthy diet that reduces salt and sugar intake
  • Get vaccinated for hepatitis A and B, the flu, and pneumococcal disease

NAFLD clinical research is so crucial today. We need clinical trials to develop treatments for NAFLD and you can help us. Participate in clinical trials to help the advancement in medicine for NAFLD. You can sign up for our current or upcoming studies by calling us at (480) 360-4000 or visiting our website.

Sources:

https://www.healio.com/news/hepatology/20210924/six-recent-reports-from-the-digital-nafld-summit-2021

https://www.healio.com/news/hepatology/20210917/researchers-deem-nafld-a-public-health-priority

https://easl.eu/press-release/treatment-advances-for-non-alcoholic-fatty-liver-disease-nafld-announced-at-ilc-2021/

https://atriumhealth.org/about-us/newsroom/news/2021/04/groundbreaking-clinical-trials-for-patients-with-nonalcoholic-fatty-liver-disease

https://medlineplus.gov/fattyliverdisease.html

Haley Wilson

Recent Posts

A New Hope in the Battle Against Fatty Liver Disease: Understanding Rezdiffra™ (resmetirom)

Today, we're talking about some exciting news for people battling fatty liver disease, specifically Nonalcoholic…

2 months ago

Rezdiffra™ (resmetirom) and NASH: A Promising Advance in Treatment

Nonalcoholic Steatohepatitis (NASH) (now known as Metabolic Dysfunction-Associated Steatohepatitis or MASH) represents a significant and…

2 months ago

World Hepatitis Day: Leading the Charge for Viral Hepatitis Elimination with Arizona Liver Health

Every year, on July 28th, the world comes together to observe World Hepatitis Day, a…

9 months ago

Men and Liver Cirrhosis: Empowering Participation in Clinical Trials for Progress

Liver cirrhosis is a chronic and potentially life-threatening condition affecting many worldwide and in Arizona.…

11 months ago

Alcohol-Related Liver Disease in Women

May is Women's Health Awareness Month, and it's more important than ever to address the…

12 months ago

The 3 Most Common Liver Scans

Have you ever wondered how well your liver is functioning? Our latest blog gives you…

1 year ago